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Solitary metastatic renal tumors are rarely encountered. We report the case of a 63-year-old man who developed
a solitary renal metastasis after undergoing an esophagectomy for esophageal squamous cell carcinoma and
subsequent nephrectomy of the right kidney.
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Esophageal cancer (EC) is one of the top six leading
causes of death from cancer; it exhibits a strikingly
uneven geographical distribution, resulting in focal
endemic high-incidence areas in several countries [1].
Although considerable advances in diagnosis, surgical
techniques and chemoradiotherapy have been made, EC
still remains one of the most lethal cancers and most pa-
tients die from its recurrence or metastasis, with a five-
year survival rate as low as 16% in 2009 in the United
States [2]. In China, the situation is even worse [3]. Al-
though 50% to 70% of patients can be treated surgically
with a chance of cure, half of the patients suffer from
local recurrences or metastasis after complete resection.
The most common sites of metastasis are the liver, lung,
bone and adrenal glands [4]. Metastases of esophageal
carcinoma in the kidney are considered to be extremely
rare, especially a unilateral renal metastasis [5]. There
are few cases that have been reported of solitary renal
metastasis of an esophageal carcinoma [6-12]. Herein, a
case of solitary, unilateral renal metastasis in a patient
after esophagectomy is reported (Table 1).* Correspondence: zjch1971@163.com; yipingzhang@yahoo.cn
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A 63-year-old man was admitted to our hospital for
an evaluation of progressive dysphagia for about one
month. A barium esophagogram demonstrated a mass
in the low esophagus. Chest and abdominal computed
tomography (CT) showed no abnormalities in other or-
gans. The patient underwent esophagectomy with stage
P-T2N0M0 in December 2008. Pathological examination
of the specimen revealed squamous cell carcinoma with
moderate differentiation. The patient was referred again
for osphyalgia nine months after the esophagectomy,
with no hematuria or any other urinary symptoms. Ab-
dominal CT and ultrasound examination showed a mass
measuring 6.5 × 1.5 cm in the right kidney (Figure 1a).
No metastatic lesions were evident at other sites. A right
nephrectomy was performed. Pathological examination
of the specimen led to a diagnosis of squamous cell car-
cinoma (Figure 1b).
The patient died of whole body metastasis and respira-
tory failure in December 2009.Discussion
The incidence of distant metastases from a resectable
esophageal carcinoma has been reported as approximately
20% to 30% [13]. Several reports demonstrated that the
most common site of spread is the abdominal lymph
nodes, followed by the liver, lung and bone. Autopsy
studies have shown that about 12% of patients dying of
cancer have renal metastases, making the kidney a com-
mon metastatic site [14]. In contrast to autopsy findings,. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Table 1 Reported cases of metastatic renal tumor of esophageal cancer
Case Sex Age Side Histology Treatment OS after renal metastasis (month)
1 [5] Male 64 Left SCC Nephrectomy Unknown
2 [10] Male 65 Right SCC Nephrectomy + Chemotherapy 6+
3 [6] Male 57 Right SCC Nephrectomy 3+
4 [6] Male 57 Right SCC Nephrectomy 2
5 [7] Male 61 Left SCC Nephrectomy + Chemotherapy 2
6 [8] Male 74 Right SCC Partial nephrectomy Unknown
7 [9] Male 50 Right SCC Nephrectomy + radiotherapy 4
8 [11] Male 62 Left SCC Chemotherapy + irradiation + nephrectomy Unknown
9 [12] Male 56 Left Epidermoid Nephrectomy 6
10 [14] Male 62 Left Epidermoid Nephrectomy 2
OS, overall survival; SCC, squamous cell carcinoma.
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be attributable to ignorance of such rare metastases while
the patient is alive. Most patients with renal metastases
are asymptomatic, despite extensive renal involvement.
Hematuria and proteinuria occur in fewer than 20% ofFigure 1 Abdominal CT scan and histological showing a kidney
metastasis of esophagus cancer. a) Abdominal CT scan showing a
mass in the right kidney. b) Histological examination revealed the
same cell type as the previous esophagus cancer. (H&E, 100).patients. Therefore, the diagnosis of renal metastases is
very difficult and it is often found accidentally.
There are some differences in clinical manifestation
between primary renal cell carcinoma and metastatic
carcinoma. Most primary renal cell carcinomas are, on
average, larger than metastatic renal tumors. Metastatic
renal tumors are frequently observed in subcapsular lo-
cations. The typical pattern of renal metastases consists
of multiple small nodules and almost all cases are associ-
ated with widespread non-renal metastases [15]. More-
over, unilateral, solitary renal metastasis is extremely
rare. With respect to the pathology, the clear cell type is
most commonly observed in primary renal cell carcin-
oma. However, squamous cell carcinoma has the highest
occurrence among metastatic renal tumors from esopha-
geal carcinoma.
Because of the rarity of renal metastasis of esophageal
carcinoma, no conclusive treatment has been established
yet according to the European Association of Urology
(EAU) guidelines and National Comprehensive Cancer
Network (NCCN) guidelines. Imada et al. [16] suggested
that an aggressive and careful surgical approach with ad-
equate follow-up may offer a chance of long-term sur-
vival for patients with multiple cancers. Grise et al. [12]
reported that solitary metastatic renal tumor could be an
indication for nephrectomy. In our case, since the tumor
seemed to be a solitary renal metastasis without any
other metastatic lesions, nephrectomy was performed.
Pathological assessment showed a single metastatic
squamous carcinoma of the same cell type as the previ-
ous esophagus cancer. The present case serves to dem-
onstrate that careful follow up is needed for esophageal
cancer patients with a cancer in another organ including
rare site metastasis.
The median survival following the detection of a re-
current or metastatic esophageal carcinoma is two to ten
months [17]. The treatment outcome of a recurrent dis-
ease is disappointing, and the prognosis is poor. In this
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survival time after esophagectomy, and recurred with a
solitary metastasis mass in the right kidney. A nephrec-
tomy was performed and the patient died of metastasis
three months later.Conclusions
In summary, a renal metastasis after anesophagectomy of
esophageal carcinoma is reported. Renal metastasis should
be considered whenever a mass in the kidney is identified.
The prognosis is poor even when surgery is performed.Consent
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